ADVANCED EPITHELIAL OVARIAN CANCER
Clinical trials for ADVANCED EPITHELIAL OVARIAN CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED EPITHELIAL OVARIAN CANCER trials appear
Sign up with your email to follow new studies for ADVANCED EPITHELIAL OVARIAN CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Ovarian cancer surgery showdown: tumor removal vs. bowel resection
Disease control Recruiting nowThis study looks at two different surgeries for advanced ovarian cancer that has spread to the bowel. One method removes only the tumor from the bowel, while the other removes a piece of the bowel along with the tumor. The goal is to see which approach helps patients live longer …
Matched conditions: ADVANCED EPITHELIAL OVARIAN CANCER
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Chemo fog inside the belly: could PIPAC boost ovarian cancer surgery success?
Disease control Recruiting nowThis study tests if giving chemotherapy as a pressurized mist directly into the abdomen (PIPAC) alongside standard IV chemo can help more women with advanced ovarian cancer have successful tumor-removal surgery. It includes 160 women aged 18-75 with stage IIIB-IIIC disease. The g…
Matched conditions: ADVANCED EPITHELIAL OVARIAN CANCER
Phase: PHASE2 • Sponsor: Moscow Regional Oncological Dispensary • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New cancer drug shows promise for Hard-to-Treat tumors and brain spread
Disease control Recruiting nowThis study tests a new drug called SPR1020 in adults with advanced solid tumors that have not responded to standard treatments. The drug is designed to target cancer cells with specific genetic changes (BRCA or HRR mutations) and may also reach brain tumors. The goal is to find a…
Matched conditions: ADVANCED EPITHELIAL OVARIAN CANCER
Phase: PHASE1, PHASE2 • Sponsor: Shanghai SciBrunch Therapeutics Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC